BridgeBio have significantly boosted the progress of an novel therapy for cardiac amyloidosis, leveraging the compound. Preliminary patient results reveals potential improvements for those suffering with a debilitating https://attr-cm883227.amoblog.com/company-progresses-amyloidosis-therapy-through-attruby-64261058